Companies / LTP

LTR PHARMA LIMITED

ASX:LTPPharmaceuticals, Biotechnology & Life Sciences
182.3M shares on issueASX (delayed) · snapshot 28 Oct 2026217.3M fully diluted+19.2% if every option and right converts$0.44price · delayed$80.2MMarket capAt the previous close. On a day the price moves, shares × today’s price will differ. Prices delayed.

Today’s holders own 83.9% of what they think they own, once every option and right converts.

Low
Dilution risk

Share count grew 18% in 24 months; options/rights overhang 19% of shares; 2% of shares in the money

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway11.1 quarters of funding
Share-count growth (24m)18.5%
Raise cadence (24m)0 cash raises
Options & rights overhang19.2% of shares
In-the-money supply2.4% of shares
Pending proposed issuesnone

LTR PHARMA LIMITED's ordinary share count grew 18.5% between July 2024 and September 2026, its latest share-count filing, to 182M shares. The company did not raise capital through any cash placement, rights issue or share purchase plan in the 24-month window. Options and rights on issue could convert into 35M new shares, equal to 19.2% of the current share count, of which 2% are in the money at the current share price; the nearest expiry falls in December 2026. The company has more than 4 quarters of funding at the recent spend rate. No proposed securities issues (Appendix 3B) are currently pending.

AI-generated summary of this page's cited filings · updated 28 Oct 2026
Quick answers · 4

How much placement capacity does LTP have left?

None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.

How much cash does LTP have?

In its quarterly cash report for the quarter ended 30 Sept 2026, Ltr Pharma reported $18.2M of cash and estimated 11.0 quarters of funding available at its current rate of spending. That is the company's own estimate.

When do LTP's options expire?

Unexercised options and rights equal 19.2% of Ltr Pharma's shares on issue; the nearest expiry is Dec 2026.

How much has LTP's share count grown?

Ltr Pharma has 182.3M shares on issue as at 28 Oct 2026, up 18.5% over 24 months according to its Appendix 2A filings.

Get told when this changes
Get LTP alerts
Free for up to 2 companies. A daily email when LTP raises money, files a new share issue, drops below 2 quarters of cash or moves risk level.
19.2%
Options & rights overhang
2.4%
In the moneyAn option whose exercise price is below the last closing share price, so converting it pays. These are the options most likely to become new shares soon. supply
0
Raises · last 12 months
11.1 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 182.3M per ASX (delayed) (snapshot 28 Oct 2026).
160M170M180MDec 24Nov 25Oct 26182.3M

Cash runway

11.1 qtrs OURS
More than four quarters of funding at the recent spend rate.
Funds operations to about July 2029 at the reported spend rate.
$17.7M cash after burn.
FILED 11.0 qtrs · $18.2M cash · quarter ended 30 Sept 2026
OURS our estimate, carried to todayOURSOur estimate for today. We take the cash in the company’s latest cash report, deduct spending since at its reported rate, and, for quarterly filers, add raises announced after it. It moves daily; announced money may not all be received yet.$18.2M cash at 30 Sep 2026 − $0.5M spent ($1.6M a quarter × 28 days) = $17.7M left → 11.1 qtrsFILED as the company reportedFILEDAs the company stated it in its latest cash report. Dated to the end of that period, it does not change until the next report.
Free account
12 cash reports on record — Cash runway history
Cash, net spend and cover trend from every Appendix 4C/5B and 4D/4E on record up to 30 Sept 2026.
Free account: 2 full company unlocks every month, no card.
Unlock LTP freeSee plans

Issuance timeline

Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
11 Sept 20262A · quoted issueLTP : ORDINARY FULLY PAID182.3MAppendix 2A
4 Sept 20262A · quoted issueLTP : ORDINARY FULLY PAID182.0MAppendix 2A
10 July 20263G · unquotedORDINARY FULLY PAID181.8MAppendix 3G
10 Feb 20262A · quoted issueLTP : ORDINARY FULLY PAID181.8MAppendix 2A
21 Jan 20262A · quoted issueLTP : ORDINARY FULLY PAID181.7MAppendix 2A
Free account
18 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Unlock LTP freeSee plans

Securities on issue over time

Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.

Free account
Securities on issue, by class
How the share count and each option and rights class moved, month by month, with every number in a table.
Free account: 2 full company unlocks every month, no card.
Unlock LTP freeSee plans

Capital raises

No equity raises in the last 24 months.
Free account
1 issue (incl. 1 exercise or conversion) on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Unlock LTP freeSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

2.3M of option supply could convert within 12 months — 1.3% of shares on issue
2.3M in the money, expiring in the window
Out-of-the-money options are excluded — at today’s price they expire rather than convert. So is condition-triggered supply, which has no expiry and no price, and convertibles that convert on their own terms rather than on a date.
Free account
6 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Unlock LTP freeSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.

No Appendix 3B in the last 12 months reports an issue under the 15% placement capacity (as at 2026-10-28).
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Unlock LTP freeSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

19.2%
Options & rights overhang · of current shares
2.4%
In-the-money supply · at current price
35.1M
Potential new shares
Dec 2026
Nearest expiry
What this supply is, and what converts it
  • Price-triggered33.3M · 18.3% of shares
    Options and warrants — they convert when the share price clears their exercise price.
    At least 14.2M of it states no exercise price — that much cannot be called in or out of the money.
  • Condition-triggered1.8M · 1.0% of shares
    Performance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.

Exercise price on record: 19.1M priced (of which 4.3M in the money), 16.0M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.

Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.

What a price move would switch on
17.5M35.1M$0.44 now0.25× today ($0.11) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.22) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($0.33) — 4.3M of the priced supply in the money, 2.4% of shares on issue1× today ($0.44) — 4.3M of the priced supply in the money, 2.4% of shares on issue1.25× today ($0.55) — 10.5M of the priced supply in the money, 5.8% of shares on issue1.5× today ($0.66) — 18.8M of the priced supply in the money, 10.3% of shares on issue2× today ($0.88) — 18.8M of the priced supply in the money, 10.3% of shares on issue3× today ($1.32) — 18.8M of the priced supply in the money, 10.3% of shares on issue5× today ($2.20) — 18.8M of the priced supply in the money, 10.3% of shares on issue10× today ($4.40) — 19.1M of the priced supply in the money, 10.5% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

At $0.44 today, 4.3M securities are in the money (2.4% of shares on issue). No more priced supply until 1.25× today’s price, which takes it to 10.5M (5.8% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 16.0M (45.6% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
CodeSecurityTypeExercise priceExpiryOn issueSource
LTPABOptionsPrice-triggered$0.2611 Dec 20262.3MFiling
LTPAIOptionsPrice-triggered$0.6016 Jan 20288.3MFiling
LTPAFOptionsPrice-triggered$2.522 Dec 2028300kFiling
LTPAGOptionsPrice-triggered$0.485 Dec 20286.0MFiling
LTPACOptionsPrice-triggered$0.2211 Dec 20282.0MFiling
LTPAHOptionsPrice-triggered$0.5015 Dec 2029200kFiling
LTPAEPerformance rightsCondition-triggered——1.8MFiling
LTPADOptionsPrice-triggered, no exercise price stated——14.2MFiling

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.

Free account
8 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Unlock LTP freeSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
19 Nov 2025Julian ChickOther incentive808k1.5M——3Y notice
19 Nov 2025Lee RodneOther incentive51.4M3.0M——3Y notice
19 Nov 2025Maja McGuireOther incentive235k1.0M——3Y notice
Free account
3 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Unlock LTP freeSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.